DOKTER MOHAMAD AL-MAKHZOMI, nucleaire geneeskunde
0844.912.461 · rovalta.com · 28/09/2026
ACTIVE
DOKTER MOHAMAD AL-MAKHZOMI, nucleaire geneeskunde
Financial year 2025 · Closed on 31/12/2025
Net result34,3 k €-17,0 %over 1 year
Gross margin66,7 k €-12,0 %over 1 year
Equity239 k €+14,2 %over 1 year
Overview
Identity
Source · BCE/KBODOKTER MOHAMAD AL-MAKHZOMI, nucleaire geneeskunde is a Private company with limited liability incorporated in 2012. Its registered office is in Overijse.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0844.912.461
- Incorporation
- 29/03/2012
- Legal form
- Private company with limited liability
- Registered office
- Fr. Verbeekstraat 212
3090 Overijse · FlandreSee on map - Contributed capital
- 12 400,00 €
- Latest accounts
- 31/12/2025
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 14 filingsTrend over 14 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 66,7 k € | -12.0% | 75,8 k € | +6.6% | 71,1 k € | +20.5% | 59 k € | -26.6% | 80,3 k € |
| EBITDA | 66,1 k € | -12.0% | 75,1 k € | +7.2% | 70,1 k € | +20.5% | 58,2 k € | -26.9% | 79,5 k € |
| Operating result | 48,6 k € | -16.7% | 58,3 k € | +10.1% | 53 k € | +30.0% | 40,7 k € | -34.4% | 62,1 k € |
| Net result | 34,3 k € | -17.0% | 41,3 k € | +10.5% | 37,4 k € | +32.1% | 28,3 k € | -35.3% | 43,8 k € |
| Balance sheet | |||||||||
| Equity | 239 k € | +14.2% | 209,2 k € | +19.9% | 174,5 k € | +27.3% | 137,1 k € | +18.7% | 115,5 k € |
| Total assets | 250,6 k € | +12.3% | 223,2 k € | +13.2% | 197,1 k € | +6.5% | 185,1 k € | +5.8% | 174,9 k € |
| Cash | 50 k € | +25.6% | 39,8 k € | +81.1% | 22 k € | +15123% | 144,5 € | -97.4% | 5,5 k € |
| Debts | 11,6 k € | -17.2% | 14 k € | -38.3% | 22,6 k € | -52.9% | 48 k € | -19.2% | 59,4 k € |
Valuation
Indicative valuation
As an indication, this company is worth
between 250 k€ and 500 k€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Mohamad Jawad Al-Makhzomi | Directorsince 29/03/2012Administrator - managersince 29/03/2012endedManagersince 29/03/2012ended |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 20/07/2026 | 28/08/2025 | 25/10/2024 | 22/12/2023 | 31/08/2022 | 31/08/2021 |
| General meeting | 24/04/2026 | 25/04/2025 | 26/04/2024 | 28/04/2023 | 29/04/2022 | 30/04/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 14 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 24/04/2026 | 20/07/2026 | Dutch | |
| Micro model | 31/12/2024 | 25/04/2025 | 28/08/2025 | Dutch | |
| Micro model | 31/12/2023 | 26/04/2024 | 25/10/2024 | Dutch | |
| Micro model | 31/12/2022 | 28/04/2023 | 22/12/2023 | Dutch | |
| Micro model | 31/12/2021 | 29/04/2022 | 31/08/2022 | Dutch | |
| Micro model | 31/12/2020 | 30/04/2021 | 31/08/2021 | Dutch | |
| Micro model | 31/12/2019 | 24/04/2020 | 31/08/2020 | Dutch | |
| Micro model | 31/12/2018 | 26/04/2019 | 30/07/2019 | Dutch | |
| Micro model | 31/12/2017 | 27/04/2018 | 11/06/2018 | Dutch | |
| Micro model | 31/12/2016 | 28/04/2017 | 23/08/2017 | Dutch | |
| Abridged model | 31/12/2015 | 29/04/2016 | 28/12/2016 | Dutch | |
| Abridged model | 31/12/2014 | 24/04/2015 | 08/03/2016 | Dutch | |
| Abridged model | 31/12/2013 | 25/04/2014 | 07/06/2014 | Dutch | |
| Abridged model | 31/12/2012 | 26/04/2013 | 30/08/2013 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 250 k€ and 500 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Mohamad Jawad Al-Makhzomi | Directorsince 29/03/2012Administrator - managersince 29/03/2012endedManagersince 29/03/2012ended |
Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsYear
Identity
Incorporation
Name
Registered office
Annual accounts
Filings14 filings
Mandates
Mohamad Jawad Al-Makhzomi
201220132014201520162017201820192020202120222023202420252026
Mohamad Al-Makhzomi, nucleaire geneeskunde
Fr. Verbeekstraat 212, 3090 Overijse
Director
CurrentPlanned, not yet servedEndedAccounts filedToday
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Fr. Verbeekstraat 212, 3090 OverijseCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00319320 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| DOKTER MOHAMAD AL-MAKHZOMI, nucleaire geneeskundeCurrent | CBE | |
| Mohamad Al-Makhzomi, nucleaire geneeskunde | accounts 2021 → 2025 | Accounts 2025 · 2026-00319320 |
Events
- 2025Annual accounts 202534,3 k €↓
- 2024Annual accounts 202441,3 k €↑
- 2023Annual accounts 202337,4 k €↑
- 2022Annual accounts 202228,3 k €↓
- 2021Annual accounts 202143,8 k €↑
- 2020Annual accounts 202025,1 k €↑
- 2019Annual accounts 20194,5 k €↓
- 2018Annual accounts 20186,6 k €↓
- 2017Annual accounts 20178,9 k €↑
- 2016Annual accounts 2016-2,6 k €↓
- 2015Annual accounts 20153 k €↓
- 2014Annual accounts 20148,3 k €↓
- 2013Annual accounts 201313 k €↑
- 2012Annual accounts 2012-7,5 k €
- 29/03/2012IncorporationPrivate company with limited liability